Henry Schein, Inc. (NASDAQ:HSIC) Shares Purchased by Barclays PLC

Barclays PLC boosted its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 6.9% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 286,475 shares of the company's stock after purchasing an additional 18,458 shares during the period. Barclays PLC owned approximately 0.23% of Henry Schein worth $20,882,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of the stock. Cromwell Holdings LLC raised its stake in shares of Henry Schein by 93.4% in the third quarter. Cromwell Holdings LLC now owns 352 shares of the company's stock worth $26,000 after purchasing an additional 170 shares during the last quarter. Summit Securities Group LLC acquired a new position in Henry Schein in the 2nd quarter worth approximately $31,000. Blue Trust Inc. raised its position in Henry Schein by 104.2% during the 2nd quarter. Blue Trust Inc. now owns 931 shares of the company's stock worth $60,000 after buying an additional 475 shares during the last quarter. Farther Finance Advisors LLC lifted its stake in Henry Schein by 58.9% during the 3rd quarter. Farther Finance Advisors LLC now owns 933 shares of the company's stock valued at $68,000 after acquiring an additional 346 shares during the period. Finally, Livforsakringsbolaget Skandia Omsesidigt boosted its holdings in shares of Henry Schein by 282.1% in the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,490 shares of the company's stock valued at $109,000 after acquiring an additional 1,100 shares during the last quarter. Institutional investors and hedge funds own 96.62% of the company's stock.

Henry Schein Price Performance

HSIC traded down $0.43 during trading on Friday, hitting $76.60. The company's stock had a trading volume of 1,850,698 shares, compared to its average volume of 1,405,391. The firm has a market capitalization of $9.55 billion, a price-to-earnings ratio of 31.52, a P/E/G ratio of 2.31 and a beta of 0.87. Henry Schein, Inc. has a twelve month low of $63.67 and a twelve month high of $82.63. The business's fifty day simple moving average is $72.25 and its 200 day simple moving average is $70.06. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.17 by $0.05. The firm had revenue of $3.17 billion for the quarter, compared to analysts' expectations of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The firm's revenue for the quarter was up .4% compared to the same quarter last year. During the same quarter last year, the company earned $1.32 EPS. On average, equities research analysts forecast that Henry Schein, Inc. will post 4.78 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the stock. Barrington Research reissued an "outperform" rating and set a $82.00 target price on shares of Henry Schein in a report on Wednesday, November 6th. Mizuho started coverage on Henry Schein in a research report on Wednesday, December 4th. They set a "neutral" rating and a $75.00 price target on the stock. Evercore ISI boosted their price objective on Henry Schein from $70.00 to $74.00 and gave the company an "in-line" rating in a report on Tuesday, October 8th. Finally, StockNews.com upgraded Henry Schein from a "sell" rating to a "hold" rating in a research note on Thursday, November 7th. Seven investment analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, Henry Schein presently has an average rating of "Moderate Buy" and an average target price of $78.89.

Insider Buying and Selling

In other news, COO Michael S. Ettinger sold 12,240 shares of Henry Schein stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $75.00, for a total value of $918,000.00. Following the sale, the chief operating officer now directly owns 87,706 shares of the company's stock, valued at $6,577,950. The trade was a 12.25 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 1.14% of the company's stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.